Modern Chinese Medicine R&D Department, established in 2000, consists of a number of licensed pharmacists and senior engineers. R&D department possesses several sets of experimental equipment and analytical instruments such as supercritical CO2 extraction equipments, molecular distillation equipment, GC, HPLC, GC-MS, HPLC-MS, which represents our strong research power in quality standard modernization of traditional Chinese medicine. More than 20 new and me-too Chinese medicines including Class V has been registered. Some is permitted to produce and others are in clinical trial.

The basic concept and methodology of our company for developing modern Chinese medicine is: maintaining the combination features of traditional Chinese traditional medicine under the direction of Chinese medical theories, unifying the standard and therapeutic effect by means of extracting and separating the effective ingredients from Chinese medicinal materials. We believe that the modernization of Traditional Chinese Medicine mainly lies on the modernization and industrialization of the extraction technology.

We have founded a high & new separation technology platform on which there are more than 20 year-developed, world-leading industrialized technology, supercritical CO2 extraction and molecular distillation, as core, and other technologies. On this platform, the effective ingredients in various Chinese medicinal materials such as Danshen Root, Officinal Magnolia Bark, Dried Ginger, Common Andrographis Herb and Wild Chrysanthemum Flower, have been successfully extracted and isolated, and a variety of new Chinese medicine have been developed.

Supercritical CO2 extraction technique
The solubility of the effective ingredients of natural materials in supercritical CO2 varies with the temperature and pressure. Thus, isolating and refining the natural products and biologically active substances is under the condition of relative low temperature and high pressure, and the nearly perfect green products are produced.